Hormone Therapy and Your Heart: What the Science Used to Say, What It Says Now, and What We Still Don’t Know

You finally worked up the nerve to ask about hormones. The hot flashes are wrecking your sleep, your mood is all over the place, and you walked into that appointment ready to ask for help. And then you heard it: “Hormones are risky for your heart. I wouldn’t go there.” So you didn’t. You white-knuckled your way through the night sweats and the brain fog because a seven-minute visit left you more scared than informed. Here’s what I want you to know… that warning was built on a story that science has spent 20 years rewriting. And this month, a study of more than 52,000 women added a big new chapter. Let’s walk through it together: what we used to believe, what the newest research actually shows, and the honest unknowns nobody should gloss over.

What did we used to believe about hormones and your heart?

For most of the 1990s, hormone therapy was practically handed out as heart protection. Doctors believed it kept women’s arteries young. Then came 2002. That year, a huge study called the Women’s Health Initiative stopped one of its trials early and sounded the alarm: women taking a common estrogen-plus-progestin pill appeared to have more heart disease, strokes, blood clots, and breast cancer, not less. The news went off like a bomb. Within months, millions of women threw out their prescriptions and doctors stopped offering hormones almost overnight. Use dropped by more than half. And honestly? At the time, that caution made sense. But here’s the piece that got lost in the headlines: the women in that study were, on average, 63 years old. Many were a decade or more past menopause, and some already had quietly aging arteries before they ever started hormones. That one detail would turn out to change everything. Because starting hormones in your early 50s, when symptoms actually hit, is a very different thing from starting them at 63, although even that is up for debate these days. The 2002 headlines never made that distinction. So a whole generation of women (maybe you or your mom) got a blanket “no” that was never meant to apply to all of us.

What does the newest research actually show?

Over the past two decades, researchers went back and looked closer, and a clearer picture emerged. When women start hormone therapy near the start of menopause, under age 60 or within about 10 years of their last period, the heart risks look very different from what the 2002 headlines suggested. This is often called the “timing hypothesis”: when you start matters as much as whether you start. Now add this month’s news. At the American Heart Association’s big scientific meeting (held in Chicago this month, November 2026), researchers shared data on 52,330 women ages 45 to 59 who had no history of heart disease. They followed them for about 12 years. Half had started hormone therapy; half hadn’t. The results? The two groups looked almost identical:

• Heart attack, stroke, or related heart disease: 4.4% of hormone users versus 4.6% of non-users
• Death before age 80: 1.3% versus 1.2%
• Blood clots: 0.33% in both groups

In plain English: in women who started in their mid-40s to late 50s, hormone therapy did not raise the risk of heart attack, stroke, clots, or early death. And it didn’t seem to matter much whether they used a pill, a patch, or a gel. This fits a bigger shift in the field. In 2026, the American College of Obstetricians and Gynecologists (ACOG) expanded its guidance and now treats hormone therapy as a first-line option for menopause symptoms in healthy women under 60, not a last resort you have to beg for. The ground really has moved.

What do we still NOT know?

First, this new study is preliminary. It was presented at a conference and has not yet been through peer review, the step where other scientists pick it apart before it’s published. Early findings sometimes shift once that happens. Second, it’s observational. That means researchers watched what happened to women who did or didn’t take hormones; they didn’t randomly assign it. So it can show that hormone therapy wasn’t linked to more heart problems, but it can’t prove hormones were the reason women did well. The women who chose hormones may have been healthier or more active to begin with. A few more honest gaps:

• It looked at whether women started hormones, not every switch in dose or type over the years.
• It can’t tell you about your heart. Your family history, blood pressure, clotting risk, and how far out from menopause you are all still a conversation that needs to be had.
• It doesn’t erase every risk. Hormones still aren’t right for every woman.
• We have less long-term data on the newer patches and gels than we’d like, even though they look promising for lowering clot risk.

So no, this isn’t a green light for everyone to run out and get a prescription. It’s permission to stop being afraid of a conversation you were talked out of years ago.